Glaukos (NYSE:GKOS) Price Target Raised to $176.00
Glaukos (NYSE:GKOS – Get Free Report) had its price objective lifted by stock analysts at Needham & Company LLC from $149.00 to $176.00 in a report issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Needham & Company LLC’s target price points to a potential upside of […]
Glaukos (NYSE:GKOS – Get Free Report) had its price objective lifted by stock analysts at Needham & Company LLC from $149.00 to $176.00 in a report issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Needham & Company LLC’s target price points to a potential upside of […]
